Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STAT3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01245231
What this trial is testing

Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 150
Not applicableStudy completedNCT03203486
What this trial is testing

Response of NAFLD Patients to Mediterranean Diet

Who this might be right for
NAFLDSteatosis of Liver
Harokopio University 44
Not applicableUnknownNCT02202265
What this trial is testing

Polymorphisms in CD36 and STAT3 Genes and Different Dietary Interventions Among Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Instituto de Cardiologia do Rio Grande do Sul 204
Not applicableStudy completedNCT01057290
What this trial is testing

Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 75
Early research (Phase 1)WithdrawnNCT03057990
What this trial is testing

Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Montefiore Medical Center
Testing effectiveness (Phase 2)Study completedNCT02629419
What this trial is testing

CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis

Who this might be right for
Candidiasis, Chronic Mucocutaneous
Matinas BioPharma Nanotechnologies, Inc. 4
Early research (Phase 1)Study completedNCT03527147
What this trial is testing

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

Who this might be right for
NHLDLBCLNon-hodgkin's Lymphoma+1 more
Acerta Pharma BV 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02983578
What this trial is testing

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaLung Non-Small Cell Carcinoma+22 more
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670156
What this trial is testing

Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations

Who this might be right for
JAK1 GOFSTAT1 GOFSTAT3 GOF+2 more
Lisa Satter 30
Early research (Phase 1)Ended earlyNCT06188208
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Hematologic Tumors
Vividion Therapeutics, Inc. 132
Not applicableStudy completedNCT01419496
What this trial is testing

Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 40
Testing effectiveness (Phase 2)Ended earlyNCT02996448
What this trial is testing

Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome

Who this might be right for
Autosomal-dominant Hyper-IgE Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 3
Not applicableStudy completedNCT01138332
What this trial is testing

Biomarkers in Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 20
Very early researchStudy completedNCT00696176
What this trial is testing

STAT3 DECOY in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Pittsburgh 32
Early research (Phase 1)Ended earlyNCT05384119
What this trial is testing

Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
Tvardi Therapeutics, Incorporated 6
Testing effectiveness (Phase 2)Ended earlyNCT02417753
What this trial is testing

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Who this might be right for
Ovarian CancerOvarian NeoplasmsAscites+2 more
National Cancer Institute (NCI) 1
Not applicableLooking for participantsNCT00006150
What this trial is testing

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

Who this might be right for
InfectionsPneumoniaImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 600
Very early researchNot Yet RecruitingNCT06796660
What this trial is testing

Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients

Who this might be right for
Renal Insufficiency, Chronic
Liu Zhanghong 70
Early research (Phase 1)Ended earlyNCT02058017
What this trial is testing

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 9
Not applicableStudy completedNCT04423094
What this trial is testing

Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas

Who this might be right for
Glioma
University Hospital, Montpellier 8
Next Page